Azole Resistance in Veterinary Clinical Aspergillus fumigatus Isolates in the Netherlands
Mycopathologia · 2024-08 · 189 (4)
DOI: 10.1007/s11046-024-00850-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycopathologia, online erschienen am 12.06.2024. Verfasst von Marloes A M van Dijk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht, The Netherlands. m.a.m.vandijk@uu.nl. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Azoles, Drug Resistance, Fungal, Aspergillosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aspergillus fumigatus is a saprophytic fungal pathogen that causes opportunistic infections in animals and humans. Azole resistance has been reported globally in human A. fumigatus isolates, but the prevalence of resistance in isolates from animals is largely unknown. A retrospective resistance surveillance study was performed using a collection of clinical A. fumigatus isolates from various animal species collected between 2015 and 2020. Agar-based azole resistance screening of all isolates was followed by in vitro antifungal susceptibility testing and cyp51A gene sequencing of the azole-resistant isolates. Over the 5 year period 16 (11.3%) of 142 A. fumigatus culture-positive animals harbored an azole-resistant isolate. Resistant isolates were found in birds (15%; 2/13), cats (21%; 6/28), dogs (8%; 6/75) and free-ranging harbor porpoise (33%; 2/6). Azole-resistance was cyp51A mediated in all isolates: 81.3% (T-67G/)TR 34 /L98H, 12.5% TR 46 /Y121F/T289A. In one azole-resistant A. fumigatus isolate a combination of C(-70)T/F46Y/C(intron7)T/C(intron66)T/M172V/E427K single-nucleotide polymorphisms in the cyp51A gene was found. Of the animals with an azole-resistant isolate and known azole exposure status 71.4% (10/14) were azole naive. Azole resistance in A. fumigatus isolates from animals in the Netherlands is present and predominantly cyp51A TR-mediated, supporting an environmental route of resistance selection. Our data supports the need to include veterinary isolates in resistance surveillance programs. Veterinarians should consider azole resistance as a reason for therapy failure when treating aspergillosis and consider resistance testing of relevant isolates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht, The Netherlands. m.a.m.vandijk@uu.nl.
- Department of Medical Microbiology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands.
- Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht, The Netherlands.
- Wageningen Bioveterinary Research, 8221 RA, Lelystad, The Netherlands.
- Radboudumc-CWZ Center of Expertise for Mycology, 6525 GA, Nijmegen, The Netherlands.
Zitieren
APA
van Dijk, M. A. M., Buil, J. B., Tehupeiory-Kooreman, M., Broekhuizen, M. J., Broens, E. M., Wagenaar, J. A., & Verweij, P. E. (2024). Azole Resistance in Veterinary Clinical Aspergillus fumigatus Isolates in the Netherlands. Mycopathologia, 189(4). https://doi.org/10.1007/s11046-024-00850-5
Vancouver
van Dijk MAM, Buil JB, Tehupeiory-Kooreman M, Broekhuizen MJ, Broens EM, Wagenaar JA, et al. Azole Resistance in Veterinary Clinical Aspergillus fumigatus Isolates in the Netherlands. Mycopathologia. 2024;189(4). doi:10.1007/s11046-024-00850-5
BibTeX
@article{vanDijk2024,
author = {van Dijk, Marloes A M and Buil, Jochem B and Tehupeiory-Kooreman, Marlou and Broekhuizen, Marian J and Broens, Els M and Wagenaar, Jaap A and Verweij, Paul E},
title = {Azole Resistance in Veterinary Clinical Aspergillus fumigatus Isolates in the Netherlands},
journal = {Mycopathologia},
year = {2024},
volume = {189},
number = {4},
doi = {10.1007/s11046-024-00850-5}
}
EUVIMED